Dearth of mental health support during pandemic for those with chronic health problems
(University of Toronto) A new scoping review found that those with chronic health concerns, such as diabetes, heart disease, cancer, and autoimmune conditions, are not only at a higher risk of severe COVID-19 infection, they are also more likely to experience anxiety, depression or substance use during the COVID-19 pandemic. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 20, 2021 Category: International Medicine & Public Health Source Type: news

Johnson & Johnson Innovation Announces Extension Of Innovation Partnering Office at Monash University In Collaboration With Victorian State Government To Accelerate The Life-Sciences Hub
MELBOURNE, Australia, July 15, 2021 -- Johnson & Johnson Innovation announced today the extension of the Johnson & Johnson Innovation Partnering Office at Monash University's Clayton Campus in Melbourne (JJIPO@Monash) in collaboration with the Victorian State Government.This joint initiative between Johnson & Johnson Innovation, the Victorian Government and Monash University will be extended for approximately two years through June 30, 2023. The agreement will allow JJIPO@Monash to continue connecting with the Victorian innovation ecosystem, nurturing and accelerating innovative research, new product developmen...
Source: Johnson and Johnson - July 15, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

The FDA ’s New Guillain-Barre Warning For the J & J Vaccine Reflects a Small Increased Risk of the Illness
As millions of people get vaccinated against COVID-19, the U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are closely monitoring reports of side effects and adverse events among people getting immunized. On July 12, the FDA added a warning about the risk of Guillain-Barre to the single-dose Janssen/Johnson & Johnson vaccine. Anyone who receives the shot moving forward will get an updated fact sheet informing them of the small but increased risk. There have not been significant reports of the syndrome linked to the two other vaccines authorized in the U.S., made by Pfize...
Source: TIME: Health - July 13, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

FDA to announce new warning on J&J Covid vaccine after reports of link to rare autoimmune disease 
The U.S. Food and Drug Administration is set to announced a new warning that the Johnson & Johnson COVID-19 vaccine is linked to a rare autoimmune disease. (Source: the Mail online | Health)
Source: the Mail online | Health - July 13, 2021 Category: Consumer Health News Source Type: news

FDA adds new warning on Johnson & Johnson vaccine related to rare autoimmune disorder
About 100 preliminary reports of Guillain-Barré have been detected after 12.8 million doses of Johnson & Johnson vaccine were administered, the Centers for Disease Control and Prevention said in a statement. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - July 12, 2021 Category: Consumer Health News Authors: Laurie McGinley Source Type: news

Vitamin B12 deficiency: Has your overall mood changed? Low levels could be a symptom
VITAMIN B12 deficiency can be a commonplace for many. Even more so for anyone suffering with an autoimmune disease making absorbing the vitamin much harder. When a person lacks the vitamin it could affect their mood and overall mental health. (Source: Daily Express - Health)
Source: Daily Express - Health - July 9, 2021 Category: Consumer Health News Source Type: news

Why Do Black Patients Fare Worse When MS Strikes?
TUESDAY, July 6, 2021 -- While multiple sclerosis can cause a wide swath of symptoms and challenges for anyone diagnosed with the autoimmune disease, a new study finds that race may play a role in disease severity. Researchers discovered that Black... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 6, 2021 Category: General Medicine Source Type: news

Mouse Study Suggests Fibromyalgia Has Autoimmune Roots
When researchers injected mice with antibodies from fibromyalgia patients, the animals developed symptoms of the disease--suggesting that it may be controlled by the immune system, not the nervous... (Source: The Scientist)
Source: The Scientist - July 2, 2021 Category: Science Tags: News & Opinion Source Type: news

NIDCR's Summer 2021 E-Newsletter
Having trouble viewing this email? View it as a Web page. NIDCR's Summer 2021 E-Newsletter In this issue: NIDCR News Funding Opportunities & Related Notices NIH/HHS News Subscribe to NICDR News Science Advances   Grantee News   NIDCR News NIDCR to Release Report on Oral Health in America As a 20-year follow-up to the seminal Oral Health in America: A Report of the Surgeon General, NIDCR will release Oral Health in America: Advances and Challenges in the fall of 2021. The report will illuminate new directions...
Source: NIDCR Science News - July 1, 2021 Category: Dentistry Source Type: news

Inova Diagnostics Announces FDA 510(k) Clearance for Aptiva(R), a Digital Multi-Analyte System
SAN DIEGO, June 29, 2021 -- (Healthcare Sales & Marketing Network) -- Inova Diagnostics, a worldwide leader in IVD systems and reagents for autoimmune disease in the clinical laboratory, is pleased to announce FDA 510(k) clearance of its Aptiva® Syste... Diagnostics, FDA Inova Diagnostics, Aptiva (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 29, 2021 Category: Pharmaceuticals Source Type: news

3 things that support robust biopharmaceutical research and development
Rapid advances in scientific discovery have ushered in a new era of medicine, transforming our ability to treat, and in some cases cure, many of the most challenging diseases, including cancer, rare diseases and autoimmune conditions.  (Source: The Catalyst)
Source: The Catalyst - June 29, 2021 Category: Pharmaceuticals Authors: Richard Moscicki, M.D. Tags: Research and Development PDUFA & D Focus Source Type: news

'Holiday food poisoning left me paralysed'
Malcolm Brown developed a rare autoimmune disease after suffering food poisoning while on a self-catering trip. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - June 29, 2021 Category: Consumer Health News Source Type: news

Israeli study links Pfizer vaccine to deadly blood disease that causes blood clots
(Natural News) Israeli researchers have found that Pfizer’s COVID-19 vaccine is linked to a deadly blood disease that causes clots to form around the body. On Monday, June 21, researchers from the Institute of Hematology at Shamir Medical Center in central Israel announced that the Pfizer-BioNTech vaccine can cause thrombotic thrombocytopenic purpura (TTP), an autoimmune disease... (Source: NaturalNews.com)
Source: NaturalNews.com - June 28, 2021 Category: Consumer Health News Source Type: news

Roche ’s ENSPRYNG approved by European Commission as first and only at-home subcutaneous treatment for neuromyelitis optica spectrum disorder (NMOSD)
Basel, 28 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC) has approved ENSPRYNG ® (satralizumab) for the treatment of adults and adolescents from 12 years of age living with anti-aquaporin-4 antibody (AQP4-IgG) seropositive neuromyelitis optica spectrum disorder (NMOSD), as a monotherapy or in combination with immunosuppressive therapy (IST). ENSPRYNG is the first and only NMO SD treatment that is administered subcutaneously every four weeks, allowing home-dosing after appropriate training.“An NMOSD relapse can be devastating, causing permanent neurological damage ...
Source: Roche Media News - June 28, 2021 Category: Pharmaceuticals Source Type: news

Roche ’s ENSPRYNG approved by European Commission as first and only at-home subcutaneous treatment for neuromyelitis optica spectrum disorder (NMOSD)
Basel, 28 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC) has approved ENSPRYNG ® (satralizumab) for the treatment of adults and adolescents from 12 years of age living with anti-aquaporin-4 antibody (AQP4-IgG) seropositive neuromyelitis optica spectrum disorder (NMOSD), as a monotherapy or in combination with immunosuppressive therapy (IST). ENSPRYNG is the first and only NMO SD treatment that is administered subcutaneously every four weeks, allowing home-dosing after appropriate training.“An NMOSD relapse can be devastating, causing permanent neurological damage ...
Source: Roche Investor Update - June 28, 2021 Category: Pharmaceuticals Source Type: news

Third Rock launches new cell therapy startup
Third Rock has launched a new cell-therapy startup looking to use T regulatory cells to combat autoimmune diseases like MS and diabetes — and it's got $95M and a partnership with ElevateBio to help get it going. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 23, 2021 Category: American Health Authors: Rowan Walrath Source Type: news

We Used to Have a Lyme Disease Vaccine. Are We Ready to Bring One Back?
At my animal hospital in upstate New York, an epicenter of the U.S. tick epidemic, my dog Fawn lets out a whimper as the veterinarian injects her with her annual Lyme disease shot. I roll my eyes. She doesn’t know how good she has it. The injection means that if a tick bites her (and in rural New York, a tick always does), the creepy crawly will feast on dog blood that’s been supercharged with a Lyme bacteria-killing substance, and Lyme disease won’t be transmitted to Fawn. I wish I could be shot up with that superpower. Currently, there is no human vaccine for Lyme disease—even though more than two...
Source: TIME: Health - June 17, 2021 Category: Consumer Health News Authors: Mandy Oaklander Tags: Uncategorized Disease feature Source Type: news

Online mental health therapy significantly aids the isolated, immunosuppressed in pandemic
(Michigan Medicine - University of Michigan) People with the rare autoimmune disease scleroderma, who likely experience more serious isolation during a global pandemic, saw their anxiety and depression improve after receiving online mental health intervention through an international study. Researchers say the program could be extended to many vulnerable patient populations moving forward. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - June 16, 2021 Category: Infectious Diseases Source Type: news

First test to detect recently discovered autoimmune disease associated with testicular cancer
Mayo Clinic Laboratories has launched a first-of-its-kind test to detect an autoimmune disease called testicular cancer-associated paraneoplastic encephalitis. The test, available nationally and internationally, detects the Kelch-like protein 11 antibody, or KLHL11, and is a result of the breakthrough study from 2019 that discovered the disease. This test has already provided patients, such as Steven Wopperer of [...] (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - June 16, 2021 Category: Hospital Management Source Type: news

Understanding the impact of patient empowerment and remote management in rheumatoid arthritis
(European Alliance of Associations for Rheumatology) Rheumatoid arthritis (RA) is an inflammatory autoimmune disease that causes pain, swelling and stiffness in the joints. It can also cause fatigue, and the underlying inflammation may affect other body systems. In people with RA, low empowerment is associated with worse health. Interventions to improve empowerment may include helping people to master their pain, increase physical function, and improve physical activity. Remote technologies to support patient-reported self-assessment may help improve patient empowerment and disease management. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2021 Category: International Medicine & Public Health Source Type: news

Investors pile on Stanford spinout promising new ways to attack cancer, autoimmune diseases
Inflammation-signaling cytokines are infamously tough to control. Here's why this startup thinks it can harness their potential — and top-drawer investors have now ponied up close to $200 million over two years. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 11, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Investors pile on Stanford spinout promising new ways to attack cancer, autoimmune diseases
Inflammation-signaling cytokines are infamously tough to control. Here's why this startup thinks it can harness their potential — and top-drawer investors have now ponied up close to $200 million over two years. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - June 11, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

Investors pile on Stanford spinout promising new ways to attack cancer, autoimmune diseases
Inflammation-signaling cytokines are infamously tough to control. Here's why this startup thinks it can harness their potential — and top-drawer investors have now ponied up close to $200 million over two years. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - June 10, 2021 Category: Health Management Authors: Ron Leuty Source Type: news

The molecular underpinnings of immune cell migration
This study may help develop novel therapies against autoimmune diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 7, 2021 Category: International Medicine & Public Health Source Type: news

Covid warning: Catching coronavirus may lead to an autoimmune disease, scientists say
A CORONAVIRUS infection may trigger an autoimmune process where the immune system is misdirected to attack itself, scientists say. This could be behind any unexpected symptoms felt much longer after the infection has cleared up. (Source: Daily Express - Health)
Source: Daily Express - Health - June 6, 2021 Category: Consumer Health News Source Type: news

Covid warning: Catching coronavirus is linked to an autoimmune disease, scientists say
A CORONAVIRUS infection may trigger an autoimmune process where the immune system is misdirected to attack itself, scientists say. This could be behind any unexpected symptoms felt much longer after the infection has cleared up. (Source: Daily Express - Health)
Source: Daily Express - Health - June 6, 2021 Category: Consumer Health News Source Type: news

Are There Clinically Meaningful Differences Between anti-COVID-19 Vaccines?
A health worker prepares to administer the COVID-19 vaccine to her colleague at a hospital in Mogadishu, Somalia.In a video message on May 24 to the World Health Assembly , the decision-making body of UN agency WHO, UN Secretary-General Antonio Guterres warned against the dangers of “a two-speed global response”, a concern he has frequently expressed. “Sadly, unless we act now, we face a situation in which rich countries vaccinate the majority of their people and open their economies, while the virus continues to cause deep suffering by circling and mutating in the poorest countries,” he said. Credi...
Source: IPS Inter Press Service - Health - May 28, 2021 Category: International Medicine & Public Health Authors: Sunil J. Wimalawansa Tags: Aid Development & Aid Featured Global Headlines Health Humanitarian Emergencies IPS UN: Inside the Glasshouse Poverty & SDGs TerraViva United Nations Source Type: news

Experimental Treatment Offers New Hope Against Lupus
A small, early "phase 1" trial finds an experimental antibody therapy may help ease skin symptoms from the autoimmune disease lupus. (Source: WebMD Health)
Source: WebMD Health - May 27, 2021 Category: Consumer Health News Source Type: news

Experimental Treatment Offers New Hope Against Lupus
THURSDAY, May 27, 2021 -- An experimental antibody therapy may help ease skin symptoms from the autoimmune disease lupus, a small preliminary trial suggests. Researchers found that a higher-dose version of the drug spurred a " clinically meaningful " ... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 27, 2021 Category: General Medicine Source Type: news

Long-COVID-19 Patients Are Getting Diagnosed With Little-Known Illnesses Like POTS
The day Dr. Elizabeth Dawson was diagnosed with COVID-19, she awoke feeling as if she had a bad hangover. Four months later, in February 2021, she tested negative for the virus, but her symptoms have only worsened. Dawson is among what Dr. David Goldstein, head of the National Institutes of Health’s Autonomic Medicine Section, called “waves and waves” of “long-haul” COVID patients who remain sick long after testing negative for the virus. A significant percentage are suffering from syndromes that few doctors understand or treat, primarily postural orthostatic tachycardia syndrome (POTS) and ch...
Source: TIME: Health - May 27, 2021 Category: Consumer Health News Authors: Cindy Loose / Kaiser Health News Tags: Uncategorized COVID-19 Source Type: news

Common Immune Drug Methotrexate May Hamper Response to COVID-19 Vaccine
WEDNESDAY, May 26, 2021 -- A widely used medicine for autoimmune diseases may lower people's immune response to the Pfizer mRNA COVID-19 vaccine, a new study suggests. The drug, called methotrexate, is often given to patients with immune-mediated... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 26, 2021 Category: General Medicine Source Type: news

Biotech firm Asylia Therapeutics raises $14.5M, names founding CEO
Houston-based biotechnology firm Asylia Therapeutics Inc. raised $14.5 million to advance its clinical trials for cancer drugs. The Series A round was led by Houston-based Sporos Bioventures, Asylia announced May 25. The company will use proceeds to bring Asylia's assets to first-in-human clinical trials for oncology. Asylia could potentially generate proof-of-concept signals for its clinical assets in treating autoimmune diseases like lupus, the firm said. "While cancer research has come a significant… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 25, 2021 Category: Biotechnology Authors: Chris Mathews Source Type: news

European Commission approves PONVORYTM (ponesimod), a Once Daily, Oral Therapy for the Treatment of Adults with Relapsing Forms of Multiple Sclerosis with Active Disease Defined by Clinical or Imaging Features
BEERSE, BELGIUM, May 24, 2021 – Janssen, the Pharmaceutical Companies of Johnson & Johnson, announced today that the European Commission (EC) has approved PONVORY (ponesimod) for the treatment of adult patients with relapsing multiple sclerosis (RMS) with active disease defined by clinical or imaging features.[4] “Relapsing multiple sclerosis is an unpredictable and complex disease that can present very differently from individual to individual, placing a heavy burden on the patient and their loved ones,” said Professor Gavin Giovannoni, MBBCh, PhD, FCP (Neurol., SA), FRCP, FRCPath, Professor of Neuro...
Source: Johnson and Johnson - May 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Novel immune checkpoints have applications for cancer, autoimmune disease treatment
(University of Connecticut) Dr. Laijun Lai, a research professor in the Department of Allied Health Sciences in the College of Agriculture, Health and Natural Resources, has used bioinformatics and gene engineering techniques to develop a series of recombinant proteins and antibodies for a novel set of checkpoint molecules for potential cancer and autoimmune disease treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 20, 2021 Category: International Medicine & Public Health Source Type: news

Rogue antibodies wreak havoc in severe COVID-19 cases
The development of antibodies to the COVID-19 virus has been the great long-term hope of ending the pandemic. However, immune system turncoats are also major culprits in severe cases of COVID-19, Yale scientists report in the journal Nature. These autoantibodies target and react with a person's tissues or organs similar to ones that cause autoimmune diseases such as lupus or rheumatoid arthritis. (Source: World Pharma News)
Source: World Pharma News - May 19, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

How strengthening the biosimilar marketplace benefits patients
Biologics are medicines that are made from living organisms through highly complex manufacturing processes and include a wide variety of medicines such as therapeutic proteins, monoclonal antibodies and vaccines. They are used to prevent or treat a variety of diseases including cancer, chronic kidney disease, diabetes, cystic fibrosis and autoimmune disorders.  (Source: The Catalyst)
Source: The Catalyst - May 18, 2021 Category: Pharmaceuticals Tags: FDA Drug Cost Biologics and Biosimilars Source Type: news

Adverse childhood experience in patients with psoriasis - Akamine AA, Rusch GS, Nisihara R, Skare TL.
INTRODUCTION: Adverse childhood experiences (ACEs) have been linked to the occurrence of autoimmune diseases in adults, including psoriasis. AIM: To study the prevalence of ACEs in psoriasis patients comparing it with general population. ME... (Source: SafetyLit)
Source: SafetyLit - May 17, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Stanford study reveals new biomolecule
(Stanford University) A newfound biomolecule, consisting of RNA modified by sugars, could be present in all forms of life and might contribute to autoimmune disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 17, 2021 Category: Biology Source Type: news

Vitamin B12 deficiency: Six symptoms indicating you may be at risk of pernicious anaemia
VITAMIN B12 deficiency can be a commonplace for many. Even more so for anyone suffering with an autoimmune disease making absorbing the vitamin much harder. What are six symptoms indicating you may have this condition? (Source: Daily Express - Health)
Source: Daily Express - Health - May 16, 2021 Category: Consumer Health News Source Type: news

Is Ulcerative Colitis an Autoimmune Disease?
Title: Is Ulcerative Colitis an Autoimmune Disease?Category: Diseases and ConditionsCreated: 5/14/2021 12:00:00 AMLast Editorial Review: 5/14/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - May 14, 2021 Category: Nutrition Source Type: news

UCLA scientists decode the ‘language’ of immune cells
UCLA life scientists have identified six “words” that specific immune cells use to call up immune defense genes — an important step toward understanding the language the body uses to marshal responses to threats.In addition, they discovered that the incorrect use of two of these words can activate the wrong genes, resulting in the autoimmune disease known as Sj ögren’s syndrome. The research, conducted in mice,is published this week in the peer-reviewed journal Immunity (Cell Press).“Cells have evolved an immune response code, or language,” said senior author Alexander Hoffmann...
Source: UCLA Newsroom: Health Sciences - May 12, 2021 Category: Universities & Medical Training Source Type: news

UCLA scientists decode the 'language' of immune cells
(University of California - Los Angeles) UCLA scientists have identified 'words' immune cells use to call up immune defense genes -- an important step toward understanding their language. The scientists also discovered that in an autoimmune disease, Sj ö gren's syndrome, two of these words are used incorrectly, activating the wrong genes and triggering the disease. Senior author, UCLA Professor Alexander Hoffmann, compares decoding the language of immune cells to when archaeologists discovered the Rosetta stone and could begin to read Egyptian hieroglyphs. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 12, 2021 Category: Infectious Diseases Source Type: news

Rheumatoid arthritis: Non-joint symptoms that may precede joint symptoms by five years
RHEUMATOID arthritis is a long-term condition that causes pain, swelling and stiffness in the joints. Research suggests there are also a number of symptoms that might not seem "clearly related" to the autoimmune disease. (Source: Daily Express - Health)
Source: Daily Express - Health - May 11, 2021 Category: Consumer Health News Source Type: news

Most frequently asked questions in rheumatology clinics answered
(World Scientific) May 1, 2021 - Rheumatologists in Hong Kong joined hands to develop a set of consensus statements on COVID-19 vaccination for local adult patients with autoimmune rheumatic diseases. These timey statements would serve to be a guide for rheumatologists, other specialists, family physicians, specialty nurses, and the public regarding COVID-19 vaccination for patients with rheumatic diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 11, 2021 Category: International Medicine & Public Health Source Type: news

Defective epithelial barriers linked to two billion chronic diseases
(University of Zurich) Humans are exposed to a variety of toxins and chemicals every day. According to the epithelial barrier hypothesis, exposure to many of these substances damages the epithelium, the thin layer of cells that covers the surface of our skin, lungs and intestine. Defective epithelial barriers have been linked to a rise in almost two billion allergic, autoimmune, neurodegenerative and psychiatric diseases. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - May 6, 2021 Category: Biology Source Type: news

Looking to create new playbook against autoimmune diseases, startup grows $70M round
The way Genentech Inc. and other drug developers broke down cancer to get treatments to fit patients' tumors, and how heart drug maker Myokardia Inc. zeroed in on narrow subsets of heart disease to get the right drug to the right person, a new California drug maker is emerging with $70 million to bring a new sharpened focus to autoimmune diseases. Who better to lead Esker Therapeutics Inc. than June Lee, a biotech veteran who spent time at Genentech and Myokardia? For the past year and a half,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 5, 2021 Category: American Health Authors: Ron Leuty Source Type: news

Why Exercise Can Be So Draining for People With Rheumatoid Arthritis
Even a gentle session of leg lifts set off an exaggerated nervous system reaction in older women with rheumatoid arthritis. (Source: NYT Health)
Source: NYT Health - May 5, 2021 Category: Consumer Health News Authors: Gretchen Reynolds Tags: Rheumatoid Arthritis Blood Pressure Nerves and Nervous System Immune System Heart Muscles Autoimmune Diseases Coronavirus (2019-nCoV) Journal of Physiology, The Source Type: news

Study uncovers potentially avoidable acute care use for vaccine-preventable illnesses in lupus patients
(Wiley) A new study published in Arthritis Care& Research indicates that few individuals with the autoimmune disease lupus who were publicly insured through Medicaid received recommended vaccines in 2000-2010. Also, those who were unvaccinated needed more acute care for vaccine-preventable illnesses. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 5, 2021 Category: International Medicine & Public Health Source Type: news

Microneedles are promising devices for painless drug delivery with minimal side effects
(University of Helsinki) A recent study from the University of Helsinki monitors the breakthrough progresses in the development of microneedles for immunotherapy and discusses the challenges regarding their production. Researchers suggest using microneedles for immunotherapy due to the high abundance of immune cells under the skin. The aim is to vaccinate or treat different diseases, such as cancer and autoimmune disorders, with minimal invasiveness and side effects. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 5, 2021 Category: Cancer & Oncology Source Type: news

Rheumatoid arthritis: Eyes and eight other non-joint areas affected by arthritis
RHEUMATOID arthritis is an autoimmune disease, which means the body's immune system targets affected joints, which leads to pain and swelling. There are also a host of non-joint areas affected by rheumatoid arthritis. (Source: Daily Express - Health)
Source: Daily Express - Health - April 28, 2021 Category: Consumer Health News Source Type: news